Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV000625633 | SCV002775314 | uncertain significance | Polycystic kidney disease, adult type | 2022-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004025284 | SCV005006701 | uncertain significance | Inborn genetic diseases | 2023-12-05 | criteria provided, single submitter | clinical testing | The c.11681C>T (p.A3894V) alteration is located in exon 42 (coding exon 42) of the PKD1 gene. This alteration results from a C to T substitution at nucleotide position 11681, causing the alanine (A) at amino acid position 3894 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Bioscientia Institut fuer Medizinische Diagnostik Gmb |
RCV000625633 | SCV000746134 | uncertain significance | Polycystic kidney disease, adult type | 2017-09-18 | no assertion criteria provided | clinical testing |